DiaMedica Therapeutics Inc. (DMAC) financial statements (2020 and earlier)

Company profile

Business Address 2 CARLSON PARKWAY
MINNEAPOLIS, MN 55447
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1017
Cash and cash equivalents517
Short-term investments5 
Receivables11
Prepaid expense 0
Deposits current assets0 
Other undisclosed current assets0 
Total current assets:1118
Noncurrent Assets
Operating lease, right-of-use asset0
Property, plant and equipment00
Deposits noncurrent assets 0
Total noncurrent assets:00
TOTAL ASSETS:1118
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:11
Accounts payable00
Accrued liabilities1 
Employee-related liabilities 0
Other undisclosed accounts payable and accrued liabilities 0
Debt00
Total current liabilities:11
Noncurrent Liabilities
Long-term debt and lease obligation00
Finance lease, liability0
Capital lease obligations0
Operating lease, liability0
Total noncurrent liabilities:00
Total liabilities:11
Stockholders' equity
Stockholders' equity attributable to parent1017
Additional paid in capital6463
Accumulated other comprehensive income0 
Accumulated deficit(54)(46)
Total stockholders' equity:1017
TOTAL LIABILITIES AND EQUITY:1118

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
Gross profit: 1
Operating expenses(9)(7)
Operating loss:(9)(7)
Nonoperating income11
Loss from continuing operations before income taxes:(8)(6)
Income tax expense(0)(0)
Net loss available to common stockholders, diluted:(8)(6)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
Net loss:(8)(6)
Comprehensive loss:(8)(6)
Other undisclosed comprehensive income, net of tax, attributable to parent0 
Comprehensive loss, net of tax, attributable to parent:(8)(6)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: